Treating impaired consciousness with glutamyl-L-histidyl-L-prolinamide
AssigneeTakeda Chemical Industries, Ltd.
InventorsYoshinao Takahashi, Kazuo Takeuchi
Life of this patent
Estimating the term…
Abstract
The impaired consciousness due to functional or organic damage of the brain in human patients can be significantly improved and restored, without any undesirable side-effect, by administering to the patients L-pyroglutamyl-L-histidyl-L-prolinamide or its physiologically acceptable salts.
Claims5
A method for the treatment of a human patient with impaired consciousness due to cranial trauma, brain surgery, cerebrovascular disorder, or brain tumor, which comprises administering to such patient an effective amount of L-pyroglutamyl-L-histidyl-L-prolinamide or a physiologically acceptable salt thereof.
Dependencies are inferred from the claim text.